Osteofibrous Dysplasia
A 13-year-old boy presents with increasing right calf mass.
History: A 13-year-old boy presents with increasing right calf mass.
Sagittal proton density image of the area of concern:
Axial fat suppressed images through the area of concern:
Diagnosis: Osteofibrous dysplasia
Findings: Cortically based lucency of the middle tibia. No medullary involvement and without periosteal reaction. Status post bone graft packing on final images.
Comments: Osteofibrous dysplasia is a rare bone tumor of the tubular bones, most commonly in the anterior cortex of the tibia, which is often referred to as an ossifying fibroma of the tubular bones. Thought to exist within a spectrum of benign to malignant with adamantinoma. Treatment is controversial but follow up radiographs and careful observation is paramount to assess for possible degeneration to adamantinoma.
Resources:
Resnick, Kransdorf, Bone and Joint Imaging 3rd Edition. 2005.
“Osteofibrous dysplasia of the tibia. Is there a need for a radical surgical approach?” Lee RS, Weitzel S, Eastwood DM, Monsell F, Pringle J, Cannon SR, Briggs TW.
“Adamantinoma of tibia: a study of 12 cases” Desai SS, Jambhekar N, Agarwal M, Puri A, Merchant N.
EMedicine.com: Osteofibrous Dysplasia
Case courtesy Hospital for Special Surgery. Click here for more Case Studies from HSS.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
